Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Verve Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 865 shares @ $22.95, valued at $19.9k
12/01/2022 4 Dorval Allison (CFO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 554 shares @ $22.1, valued at $12.2k
Exercised 1,875 restricted stock units @ $0
11/08/2022 4 Yeshwant Krishna (10% Owner) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Disposed of 48,583 shares @ $0
Sold 47,690 shares @ $31.118, valued at $1.5M
Sold 650 shares @ $31.9905, valued at $20.8k
Sold 243 shares @ $32.9, valued at $8k
11/08/2022 4 GV 2017 GP, L.L.C. (Member of 10% Group) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Disposed of 48,583 shares @ $0
Sold 47,690 shares @ $31.118, valued at $1.5M
Sold 651 shares @ $31.9905, valued at $20.8k
Sold 242 shares @ $32.9, valued at $8k
Sold 47,690 shares @ $31.118, valued at $1.5M
Sold 650 shares @ $31.9905, valued at $20.8k
Sold 243 shares @ $32.9, valued at $8k
11/04/2022 4 Yeshwant Krishna (10% Owner) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Disposed of 28,651 shares @ $0
Sold 9,350 shares @ $34.7754, valued at $325.1k
Sold 10,372 shares @ $36.2786, valued at $376.3k
Sold 8,930 shares @ $36.775, valued at $328.4k
Disposed of 49,569 shares @ $0
Sold 22,279 shares @ $32.3155, valued at $720k
Sold 25,534 shares @ $33.1384, valued at $846.2k
Sold 1,755 shares @ $33.8373, valued at $59.4k
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2022 4 Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 6,632 shares @ $34.666, valued at $229.9k
Sold 13,368 shares @ $35.5927, valued at $475.8k
Sold 36,798 shares @ $35.3091, valued at $1.3M
Sold 3,202 shares @ $36.0336, valued at $115.4k
Exercised 40,000 options to buy @ $1.48, valued at $59.2k
Exercised 20,000 options to buy @ $1.48, valued at $29.6k
08/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2022 4 Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 50,000 shares @ $29.9, valued at $1.5M
Exercised 50,000 options to buy @ $1.39, valued at $69.5k
08/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2022 4 Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 20,000 shares @ $34.9, valued at $698k
Exercised 20,000 options to buy @ $1.39, valued at $27.8k
07/21/2022 4 Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 50,000 shares @ $29.9, valued at $1.5M
Exercised 50,000 options to buy @ $1.39, valued at $69.5k
07/15/2022 4 Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Gifted 160,000 shares @ $0
Gifted 160,000 shares @ $0
Gifted 140,000 options to buy @ $8.24, valued at $1.2M
Gifted 160,000 options to buy @ $2.87, valued at $459.2k
Gifted 140,000 options to buy @ $8.24, valued at $1.2M
Gifted 160,000 options to buy @ $2.87, valued at $459.2k
07/15/2022 4 Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 10,000 shares @ $24.9, valued at $249k
Exercised 10,000 options to buy @ $1.48, valued at $14.8k
07/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Mikhail Sheila (Director) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Granted 15,500 options to buy @ $14.04, valued at $217.6k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2022 4 Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Exercised 69,674 options to buy @ $2.87, valued at $200k
03/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 Dorval Allison (CFO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Granted 60,000 options to buy @ $30.94, valued at $1.9M
02/15/2022 4 Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Granted 332,000 options to buy @ $30.94, valued at $10.3M
02/15/2022 4 Bellinger Andrew (Chief Scientific Officer) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Granted 125,000 options to buy @ $30.94, valued at $3.9M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy